Late Renal Effects of COVID-19 in Kidney Transplant Recipients: A Single-Center Study

Bibliographic Details
Main Author: Gomes, Bruno Teixeira
Publication Date: 2025
Other Authors: Sousa, Marcos Vinicius de, Bressanin, Fernanda Garcia, Rossi, Matheus Rizzato, Mazzali, Marilda
Format: Article
Language: eng
por
Source: Brazilian Journal of Transplantation
Download full: https://bjt.emnuvens.com.br/revista/article/view/654
Summary: Introduction:  During the coronavirus disease 2019 (COVID-19) pandemic, kidney transplant recipients had higher rates of hospitalization and mortality. However, data on the late renal effects of the infection are scarce. Objectives:  This study aims to describe the evolution of renal function and proteinuria in kidney transplant recipients after the infection. Methods:  Single-center prospective cohort study. A total of 321 kidney transplant recipients who survived COVID-19 from March 2020 to December 2022 were included. Data on renal function, proteinuria, and immunosuppression were analyzed pre-infection, 3 and 6 months post-infection. Results:  Most patients were male (58.9%), with a mean age of 50 years, recipients of kidneys from deceased donors (79.4%), and with a median time after transplant of 6.6 years. There was a reduction in the level of immunosuppression, from a pre-infection Vasudev score of 4.66 to 4.50 (p< 0.001) in the 3rd month and 4.54 (p = 0.016) 6 months post-infection. The glomerular filtration rate (GFR) remained stable at around 60 mL/min/1.73 m2. The percentage of patients with proteinuria ≥ 1.0 increased from 9.6% pre-infection to more than 13% (p < 0.001) in the 3rd and 6th months after infection. Higher proteinuria levels were observed in recipients with longer follow-up post-transplant, previous rejection episodes, lower estimated GFR, and higher prevalence of donor-specific anti-HLA antibodies. Conclusions:  Kidney transplant recipients with COVID-19 had an increase in proteinuria within 6 months after the infection despite a stable GFR.
id ABTO_10e02b0a6d259a01fbea9915c0f22d38
oai_identifier_str oai:ojs3.emnuvens.com.br:article/654
network_acronym_str ABTO
network_name_str Brazilian Journal of Transplantation
repository_id_str
spelling Late Renal Effects of COVID-19 in Kidney Transplant Recipients: A Single-Center StudyEfeitos Renais Tardios de COVID-19 em Receptores de Transplante Renal: Estudo UnicêntricoTransplante de RimCOVID-19SARS-CoV-2Síndrome de COVID-19 Pós-AgudaProteinúriaKidney transplantationCOVID-19SARS-CoV-2Post-Acute COVID-19 SyndromeProteinuriaIntroduction:  During the coronavirus disease 2019 (COVID-19) pandemic, kidney transplant recipients had higher rates of hospitalization and mortality. However, data on the late renal effects of the infection are scarce. Objectives:  This study aims to describe the evolution of renal function and proteinuria in kidney transplant recipients after the infection. Methods:  Single-center prospective cohort study. A total of 321 kidney transplant recipients who survived COVID-19 from March 2020 to December 2022 were included. Data on renal function, proteinuria, and immunosuppression were analyzed pre-infection, 3 and 6 months post-infection. Results:  Most patients were male (58.9%), with a mean age of 50 years, recipients of kidneys from deceased donors (79.4%), and with a median time after transplant of 6.6 years. There was a reduction in the level of immunosuppression, from a pre-infection Vasudev score of 4.66 to 4.50 (p< 0.001) in the 3rd month and 4.54 (p = 0.016) 6 months post-infection. The glomerular filtration rate (GFR) remained stable at around 60 mL/min/1.73 m2. The percentage of patients with proteinuria ≥ 1.0 increased from 9.6% pre-infection to more than 13% (p < 0.001) in the 3rd and 6th months after infection. Higher proteinuria levels were observed in recipients with longer follow-up post-transplant, previous rejection episodes, lower estimated GFR, and higher prevalence of donor-specific anti-HLA antibodies. Conclusions:  Kidney transplant recipients with COVID-19 had an increase in proteinuria within 6 months after the infection despite a stable GFR.Introdução:  Durante a pandemia causada pela doença do coronavírus 2019 (COVID-19), os receptores de transplante renal apresentaram maiores taxas de hospitalização e mortalidade. No entanto, os dados sobre os efeitos renais tardios da infecção são escassos. Objetivos:  Este estudo tem como objetivo descrever a evolução da função renal e proteinúria em receptores de transplante renal após a infecção. Métodos:  Estudo de coorte prospectivo unicêntrico. O total de 321 receptores de transplante renal que sobreviveram à COVID-19 de março de 2020 a dezembro de 2022 foi incluído. Dados sobre função renal, proteinúria e imunossupressão foram analisados pré-infecção, 3 e 6 meses após a infecção. Resultados:  A maioria dos pacientes era do sexo masculino (58,9%), com média de idade de 50 anos, receptor de rins de doadores falecidos (79,4%) e com mediana de tempo pós-transplante de 6,6 anos. Houve redução do nível de imunossupressão, de um escore de Vasudev pré-infecção de 4,66 para 4,50 (p < 0,001) no 3º mês e 4,54 (p = 0,016) 6 meses pós-infecção. A taxa de filtração glomerular (TFG) permaneceu estável, em torno de 60 mL/min/1,73 m2. A porcentagem de pacientes com proteinúria ≥ 1,0 aumentou de 9,6% pré-infecção para mais de 13% (p < 0,001) nos 3º e 6º meses após a infecção. Níveis mais elevados de proteinúria foram observados em receptores com maior tempo de seguimento pós-transplante, episódios de rejeição prévios, menor TFG estimada e maior prevalência de anticorpos anti-HLA doador-específicos. Conclusão:  Os receptores de transplante renal com COVID-19 tiveram um aumento na proteinúria em 6 meses após a infecção, apesar de apresentarem TFG estável.  Associação Brasileira de Transplante de Órgãos (ABTO)2025-02-14info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/pdfhttps://bjt.emnuvens.com.br/revista/article/view/654Brazilian Journal of Transplantation; Vol. 28 (2025)Brazilian Journal of Transplantation; v. 28 (2025)2764-1589reponame:Brazilian Journal of Transplantationinstname:Associação Brasileira de Transplante de Órgãos (ABTO)instacron:ABTOengporhttps://bjt.emnuvens.com.br/revista/article/view/654/727https://bjt.emnuvens.com.br/revista/article/view/654/728Copyright (c) 2025 Bruno Teixeira Gomes, Marcos Vinicius de Sousa, Fernanda Garcia Bressanin, Matheus Rizzato Rossi, Marilda Mazzaliinfo:eu-repo/semantics/openAccessGomes, Bruno Teixeira Sousa, Marcos Vinicius deBressanin, Fernanda Garcia Rossi, Matheus RizzatoMazzali, Marilda2025-02-14T12:55:38Zoai:ojs3.emnuvens.com.br:article/654Revistahttps://bjt.emnuvens.com.br/revistaONGhttps://bjt.emnuvens.com.br/revista/oaibjt@abto.org.brhttps://doi.org/10.53855/2764-15892764-1589opendoar:2025-02-14T12:55:38Brazilian Journal of Transplantation - Associação Brasileira de Transplante de Órgãos (ABTO)false
dc.title.none.fl_str_mv Late Renal Effects of COVID-19 in Kidney Transplant Recipients: A Single-Center Study
Efeitos Renais Tardios de COVID-19 em Receptores de Transplante Renal: Estudo Unicêntrico
title Late Renal Effects of COVID-19 in Kidney Transplant Recipients: A Single-Center Study
spellingShingle Late Renal Effects of COVID-19 in Kidney Transplant Recipients: A Single-Center Study
Gomes, Bruno Teixeira
Transplante de Rim
COVID-19
SARS-CoV-2
Síndrome de COVID-19 Pós-Aguda
Proteinúria
Kidney transplantation
COVID-19
SARS-CoV-2
Post-Acute COVID-19 Syndrome
Proteinuria
title_short Late Renal Effects of COVID-19 in Kidney Transplant Recipients: A Single-Center Study
title_full Late Renal Effects of COVID-19 in Kidney Transplant Recipients: A Single-Center Study
title_fullStr Late Renal Effects of COVID-19 in Kidney Transplant Recipients: A Single-Center Study
title_full_unstemmed Late Renal Effects of COVID-19 in Kidney Transplant Recipients: A Single-Center Study
title_sort Late Renal Effects of COVID-19 in Kidney Transplant Recipients: A Single-Center Study
author Gomes, Bruno Teixeira
author_facet Gomes, Bruno Teixeira
Sousa, Marcos Vinicius de
Bressanin, Fernanda Garcia
Rossi, Matheus Rizzato
Mazzali, Marilda
author_role author
author2 Sousa, Marcos Vinicius de
Bressanin, Fernanda Garcia
Rossi, Matheus Rizzato
Mazzali, Marilda
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Gomes, Bruno Teixeira
Sousa, Marcos Vinicius de
Bressanin, Fernanda Garcia
Rossi, Matheus Rizzato
Mazzali, Marilda
dc.subject.por.fl_str_mv Transplante de Rim
COVID-19
SARS-CoV-2
Síndrome de COVID-19 Pós-Aguda
Proteinúria
Kidney transplantation
COVID-19
SARS-CoV-2
Post-Acute COVID-19 Syndrome
Proteinuria
topic Transplante de Rim
COVID-19
SARS-CoV-2
Síndrome de COVID-19 Pós-Aguda
Proteinúria
Kidney transplantation
COVID-19
SARS-CoV-2
Post-Acute COVID-19 Syndrome
Proteinuria
description Introduction:  During the coronavirus disease 2019 (COVID-19) pandemic, kidney transplant recipients had higher rates of hospitalization and mortality. However, data on the late renal effects of the infection are scarce. Objectives:  This study aims to describe the evolution of renal function and proteinuria in kidney transplant recipients after the infection. Methods:  Single-center prospective cohort study. A total of 321 kidney transplant recipients who survived COVID-19 from March 2020 to December 2022 were included. Data on renal function, proteinuria, and immunosuppression were analyzed pre-infection, 3 and 6 months post-infection. Results:  Most patients were male (58.9%), with a mean age of 50 years, recipients of kidneys from deceased donors (79.4%), and with a median time after transplant of 6.6 years. There was a reduction in the level of immunosuppression, from a pre-infection Vasudev score of 4.66 to 4.50 (p< 0.001) in the 3rd month and 4.54 (p = 0.016) 6 months post-infection. The glomerular filtration rate (GFR) remained stable at around 60 mL/min/1.73 m2. The percentage of patients with proteinuria ≥ 1.0 increased from 9.6% pre-infection to more than 13% (p < 0.001) in the 3rd and 6th months after infection. Higher proteinuria levels were observed in recipients with longer follow-up post-transplant, previous rejection episodes, lower estimated GFR, and higher prevalence of donor-specific anti-HLA antibodies. Conclusions:  Kidney transplant recipients with COVID-19 had an increase in proteinuria within 6 months after the infection despite a stable GFR.
publishDate 2025
dc.date.none.fl_str_mv 2025-02-14
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://bjt.emnuvens.com.br/revista/article/view/654
url https://bjt.emnuvens.com.br/revista/article/view/654
dc.language.iso.fl_str_mv eng
por
language eng
por
dc.relation.none.fl_str_mv https://bjt.emnuvens.com.br/revista/article/view/654/727
https://bjt.emnuvens.com.br/revista/article/view/654/728
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Associação Brasileira de Transplante de Órgãos (ABTO)
publisher.none.fl_str_mv Associação Brasileira de Transplante de Órgãos (ABTO)
dc.source.none.fl_str_mv Brazilian Journal of Transplantation; Vol. 28 (2025)
Brazilian Journal of Transplantation; v. 28 (2025)
2764-1589
reponame:Brazilian Journal of Transplantation
instname:Associação Brasileira de Transplante de Órgãos (ABTO)
instacron:ABTO
instname_str Associação Brasileira de Transplante de Órgãos (ABTO)
instacron_str ABTO
institution ABTO
reponame_str Brazilian Journal of Transplantation
collection Brazilian Journal of Transplantation
repository.name.fl_str_mv Brazilian Journal of Transplantation - Associação Brasileira de Transplante de Órgãos (ABTO)
repository.mail.fl_str_mv bjt@abto.org.br
_version_ 1836111235729326080